Dr. Gregory J. Shypula, M.D.

Clinical Trials

• Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

Media Releases

Get to know Hematologist-Oncologist Dr. Gregory J. Shypula, who serves patients in Avenel, New Jersey.

A skilled hematologist-oncologist, Dr. Shypula sees patients at his private practice – Gregory J. Shypula, M.D., P.A. – located in Avenel, New Jersey. He has over two decades of experience offering exceptional care and treatment for patients with cancers and blood disorders. 

Having established his private practice in 1992, Dr. Shypula and his staff are committed to providing state-of-the-art medical care in a community setting. They provide comprehensive screening, diagnosis, and treatment of various blood disorders and cancers in a compassionate and supportive environment.

Among his other titles, Dr. Shypula is the Director of the Division of Hematology/Oncology at the Raritan Bay Medical Center; a position he has held since 1996. He is also a Clinical Assistant Professor in the Department of Medicine at the Robert Wood Johnson Medical School (UMDNJ); an attending physician at Raritan Bay Medical Center, John F. Kennedy Medical Center, Rahway Hospital, and Robert Wood Johnson University Hospital; and remains affiliated with The Cancer Institute of New Jersey. 

With a broad educational background, Dr. Shypula graduated with his medical degree from Wroclaw Medical University in Poland in 1981. He then relocated to the United States, performing his internship and residency in internal medicine at Raritan Bay Medical Center in Perth Amboy, New Jersey. He then went on to complete his fellowship in the Division of Hematology and Oncology at St. Luke’s /Roosevelt Hospital in New York City. 

Subsequent to his education, the doctor attained board certification in hematology, medical oncology, and internal medicine through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

On a professional level, Dr. Shypula is an active member of the American Society of Clinical Oncology.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Throughout his line of work, Dr. Shypula has authored several articles that have been published in scientific, peer-reviewed journals. 

Among his various accolades include: Physician of the Year 2003 – The National Republican Congressional Committees Physicians Advisory Board; Distinguished Fellow of the American Academy of Oncology Award (2008); Top Doctors for Women’s Health – Castle Connolly Ltd., Inside Jersey (February 2010 & February 2011); New Jersey Best Doctors 2010 – Castle Connolly Ltd; America’s Top Oncologists 2009 – Consumers Research Council of America; Distinguished Physician of the Year 2006 – Raritan Bay Medical Center; America’s Top Physicians 2004 – 2005 (Hematology/Oncology) – Consumers Research Council of America; Top Doctors in the New York Metro Area 2001 & 2003 – Castle Connolly Ltd.; Honoree – American Cancer Society – Second Annual Look Good Feel Better Gala 2000; and Strathmore’s Who’s Who Lifetime Member.

Recommended Articles

• Inspirational Blood Cancer Survivors

  Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission

  4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...

• Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery

  It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...

• AstraZeneca Gains United States Approval for Lymphoma Drug

  Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...